Cancer immunoprevention: from mice to early clinical trials

Cancer immunoprevention: from mice to early clinical trials

Abstract Cancer immunoprevention is based on the fact that a functioning immune system controls tumor onset and development in humans and animals, thus leading to the idea that the enhancement of immune responses in healthy individuals could effectively reduce cancer risk later in life. Successful p...

Full description

Bibliographic Details
Main Authors: Arianna Palladini, Lorena Landuzzi, Pier-Luigi Lollini, Patrizia Nanni
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Immunology
Subjects:
Cancer immunoprevention
Cancer vaccines
Genetically-modified mouse models
HER-2
Oncoantigens
Online Access:http://link.springer.com/article/10.1186/s12865-018-0253-0

Internet

http://link.springer.com/article/10.1186/s12865-018-0253-0

Similar Items